{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:15:44Z","timestamp":1760015744726},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,12,3]],"date-time":"2015-12-03T00:00:00Z","timestamp":1449100800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s10096-015-2527-2","type":"journal-article","created":{"date-parts":[[2015,12,3]],"date-time":"2015-12-03T12:25:51Z","timestamp":1449145551000},"page":"187-193","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Initial antifungal strategy does not correlate with mortality in patients with candidemia"],"prefix":"10.1007","volume":"35","author":[{"given":"R.","family":"Murri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Scoppettuolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Fabbiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Giovannenze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Taccari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Milozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Posteraro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Sanguinetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Cauda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Fantoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,3]]},"reference":[{"key":"2527_CR1","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1128\/JCM.01998-13","volume":"51","author":"M Bassetti","year":"2013","unstructured":"Bassetti M, Merelli M, Righi E et al (2013) Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and Spain. J Clin Microbiol 51:4167\u20134172","journal-title":"J Clin Microbiol"},{"key":"2527_CR2","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1093\/jac\/dkq216","volume":"65","author":"DI Hsu","year":"2010","unstructured":"Hsu DI, Nguyen M, Nguyen L et al (2010) A multicentre study to evaluate the impact of timing of caspofungin administration on outcomes of invasive candidiasis in non-immunocompromised adult patients. J Antimicrob Chemother 65:1765\u20131770","journal-title":"J Antimicrob Chemother"},{"key":"2527_CR3","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/jac\/dkm212","volume":"60","author":"MD Parkins","year":"2007","unstructured":"Parkins MD, Sabuda DM, Elsayed S et al (2007) Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections. J Antimicrob Chemother 60:613\u2013618","journal-title":"J Antimicrob Chemother"},{"key":"2527_CR4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1086\/504810","volume":"43","author":"KW Garey","year":"2006","unstructured":"Garey KW, Rege M, Pai MP et al (2006) Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis 43:25\u201331","journal-title":"Clin Infect Dis"},{"key":"2527_CR5","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00134-014-3310-z","volume":"40","author":"M Bassetti","year":"2014","unstructured":"Bassetti M, Righi E, Ansaldi F et al (2014) A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality. Intensive Care Med 40:839\u2013845","journal-title":"Intensive Care Med"},{"key":"2527_CR6","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1097\/CCM.0000000000000221","volume":"42","author":"M Puig-Asensio","year":"2014","unstructured":"Puig-Asensio M, Pem\u00e1n J, Zaragoza R et al (2014) Impact of therapeutic strategies on the prognosis of candidemia in the ICU. Crit Care Med 42:1423\u20131432","journal-title":"Crit Care Med"},{"key":"2527_CR7","doi-asserted-by":"crossref","first-page":"R105","DOI":"10.1186\/cc11388","volume":"16","author":"FJ Gonz\u00e1lez de Molina","year":"2012","unstructured":"Gonz\u00e1lez de Molina FJ, Le\u00f3n C, Ruiz-Santana S et al (2012) Assessment of candidemia-attributable mortality in critically ill patients using propensity score matching analysis. Crit Care 16:R105","journal-title":"Crit Care"},{"key":"2527_CR8","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s10096-006-0159-2","volume":"25","author":"ME Falagas","year":"2006","unstructured":"Falagas ME, Apostolou KE, Pappas VD (2006) Attributable mortality of candidemia: a systematic review of matched cohort and case\u2013control studies. Eur J Clin Microbiol Infect Dis 25:419\u2013425","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2527_CR9","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","volume":"48","author":"PG Pappas","year":"2009","unstructured":"Pappas PG, Kauffman CA, Andes D et al (2009) Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 48:503\u2013535","journal-title":"Clin Infect Dis"},{"key":"2527_CR10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12039","volume":"18","author":"OA Cornely","year":"2012","unstructured":"Cornely OA, Bassetti M, Calandra T et al; ESCMID Fungal Infection Study Group (2012) ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect 18:19\u201337","journal-title":"Clin Microbiol Infect"},{"key":"2527_CR11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s15010-013-0558-0","volume":"42","author":"L Scudeller","year":"2014","unstructured":"Scudeller L, Viscoli C, Menichetti F et al (2014) An Italian consensus for invasive candidiasis management (ITALIC). Infection 42:263\u2013279","journal-title":"Infection"},{"key":"2527_CR12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2217\/fmb.14.99","volume":"10","author":"M Fantoni","year":"2015","unstructured":"Fantoni M, Murri R, Scoppettuolo G et al (2015) Resource-saving advice from an infectious diseases specialist team in a large university hospital: an exportable model? Future Microbiol 10:15\u201320","journal-title":"Future Microbiol"},{"key":"2527_CR13","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","volume":"13","author":"WA Knaus","year":"1985","unstructured":"Knaus WA, Draper EA, Wagner DP et al (1985) APACHE II: a severity of disease classification system. Crit Care Med 13:818\u2013829","journal-title":"Crit Care Med"},{"key":"2527_CR14","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s00134-003-1662-x","volume":"29","author":"MM Levy","year":"2003","unstructured":"Levy MM, Fink MP, Marshall JC et al (2003) 2001 SCCM\/ESICM\/ACCP\/ATS\/SIS International Sepsis Definitions Conference. Intensive Care Med 29:530\u2013538","journal-title":"Intensive Care Med"},{"key":"2527_CR15","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ijantimicag.2013.09.005","volume":"43","author":"H Wisplinghoff","year":"2014","unstructured":"Wisplinghoff H, Ebbers J, Geurtz L et al (2014) Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities. Int J Antimicrob Agents 43:78\u201381","journal-title":"Int J Antimicrob Agents"},{"key":"2527_CR16","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s15010-013-0455-6","volume":"41","author":"AM Tortorano","year":"2013","unstructured":"Tortorano AM, Prigitano A, Lazzarini C et al (2013) A 1-year prospective survey of candidemia in Italy and changing epidemiology over one decade. Infection 41:655\u2013662","journal-title":"Infection"},{"key":"2527_CR17","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0002-9343(02)01248-2","volume":"113","author":"SI Blot","year":"2002","unstructured":"Blot SI, Vandewoude KH, Hoste EA et al (2002) Effects of nosocomial candidemia on outcomes of critically ill patients. Am J Med 113:480\u2013485","journal-title":"Am J Med"},{"key":"2527_CR18","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1056\/NEJMoa066906","volume":"356","author":"AC Reboli","year":"2007","unstructured":"Reboli AC, Rotstein C, Pappas PG et al (2007) Anidulafungin versus fluconazole for invasive candidiasis. N Engl J Med 356:2472\u20132482","journal-title":"N Engl J Med"},{"key":"2527_CR19","doi-asserted-by":"crossref","first-page":"R253","DOI":"10.1186\/cc10514","volume":"15","author":"DH Kett","year":"2011","unstructured":"Kett DH, Shorr AF, Reboli AC et al (2011) Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: support for the 2009 IDSA treatment guidelines for candidiasis. Crit Care 15:R253","journal-title":"Crit Care"},{"key":"2527_CR20","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/jac\/dkp495","volume":"65","author":"M Ortega","year":"2010","unstructured":"Ortega M, Marco F, Soriano A et al (2010) Candida spp. bloodstream infection: influence of antifungal treatment on outcome. J Antimicrob Chemother 65:562\u2013568","journal-title":"J Antimicrob Chemother"},{"key":"2527_CR21","doi-asserted-by":"crossref","first-page":"e33705","DOI":"10.1371\/journal.pone.0033705","volume":"7","author":"M Tumbarello","year":"2012","unstructured":"Tumbarello M, Fiori B, Trecarichi EM et al (2012) Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital. PLoS One 7:e33705","journal-title":"PLoS One"},{"key":"2527_CR22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/1471-2334-11-261","volume":"11","author":"AC Reboli","year":"2011","unstructured":"Reboli AC, Shorr AF, Rotstein C et al (2011) Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome. BMC Infect Dis 11:261","journal-title":"BMC Infect Dis"},{"key":"2527_CR23","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1086\/653935","volume":"51","author":"M Nucci","year":"2010","unstructured":"Nucci M, Anaissie E, Betts RF et al (2010) Early removal of central venous catheter in patients with candidemia does not improve outcome: analysis of 842 patients from 2 randomized clinical trials. Clin Infect Dis 51:295\u2013303","journal-title":"Clin Infect Dis"},{"key":"2527_CR24","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/cid\/cis305","volume":"54","author":"M Kollef","year":"2012","unstructured":"Kollef M, Micek S, Hampton N et al (2012) Septic shock attributed to Candida infection: importance of empiric therapy and source control. Clin Infect Dis 54:1739\u20131746","journal-title":"Clin Infect Dis"},{"key":"2527_CR25","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3201\/eid1801.110556","volume":"18","author":"E Dannaoui","year":"2012","unstructured":"Dannaoui E, Desnos-Ollivier M, Garcia-Hermoso D et al; French Mycoses Study Group (2012) Candida spp. with acquired echinocandin resistance, France, 2004\u20132010. Emerg Infect Dis 18:86\u201390","journal-title":"Emerg Infect Dis"},{"key":"2527_CR26","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/cid\/cit136","volume":"56","author":"BD Alexander","year":"2013","unstructured":"Alexander BD, Johnson MD, Pfeiffer CD et al (2013) Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Clin Infect Dis 56:1724\u20131732","journal-title":"Clin Infect Dis"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-015-2527-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-015-2527-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-015-2527-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T09:35:18Z","timestamp":1559122518000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-015-2527-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,3]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["2527"],"URL":"https:\/\/doi.org\/10.1007\/s10096-015-2527-2","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,3]]}}}